Kabra Drugs

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE323K01017
  • NSEID:
  • BSEID: 524322
INR
28.85
-1.06 (-3.54%)
BSENSE

Dec 05

BSE+NSE Vol: 74.26 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'20
Mar'19
Mar'18
Mar'17
Mar'16
Mar'15
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2020 is 0.00% vs -100.00% in Mar 2019

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2020 is 63.35% vs 86.86% in Mar 2019

stock-summary

Interest

YoY Growth in year ended Mar 2020 is -84.14% vs -97.11% in Mar 2019

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2020 is 63.83% vs 93.01% in Mar 2019

Compare Profit and Loss Results of Kabra Drugs
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
0.00
36.00
-36.00
-100.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
0.00
36.00
-36.00
-100.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
28.00
-28.00
-100.00%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
4.00
-4.00
-100.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
0.00
33.00
-33.00
-100.00%
Operating Profit (PBDIT) excl Other Income
0.00
3.00
-3.00
-100.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
0.00
3.00
-3.00
-100.00%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
0.00
2.00
-2.00
-100.00%
Depreciation
0.00
1.00
-1.00
-100.00%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
0.00
0.00
0%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
0.00
0.00
0.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-4.00
14.00
-18.00
-128.57%
Profit Available for appropriations
-4.00
15.00
-19.00
-126.67%
Appropriations
-4.00
15.00
-19.00
-126.67%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-0.14
0.3
-0.44
-146.67%
Profit And Loss - Net Sales
Net Sales 0.00 Cr
in Mar 2020

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2020 is 0.00% vs -100.00% in Mar 2019

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.05 Cr
in Mar 2020

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2020 is 63.35% vs 86.86% in Mar 2019

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2020

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2020 is -84.14% vs -97.11% in Mar 2019

Profit And Loss - Profit After Tax
Profit After Tax -0.06 Cr
in Mar 2020

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2020 is 63.83% vs 93.01% in Mar 2019